Blue Dye 2 vs Sodium Benzoate: which is worse?

What is Blue Dye 2?

Blue Dye 2 (Indigotine/Indigo Carmine) is a synthetic disulfonated derivative of indigo. Unlike natural indigo from the indigo plant, the FD&C version is synthetically manufactured from petroleum. It produces a dark royal blue to indigo color and is used in food, pharmaceuticals, and medical diagnostics.

What is Sodium Benzoate?

Sodium benzoate is the sodium salt of benzoic acid (C7H5NaO2). In acidic foods and beverages, it converts to benzoic acid, which inhibits microbial growth. While benzoic acid occurs naturally in some fruits and spices at low levels, the commercial preservative is synthetically manufactured.

Documented risks

Blue Dye 2: Animal studies conducted in the 1980s found that high-dose Blue Dye 2 caused brain tumors in male rats. An NTP bioassay (1987) found statistically significant increases in brain gliomas (astrocytomas) in male rats given high doses. The FDA reviewed these findings and determined that the doses far exceeded typical human dietary exposure. Nonetheless, the tumor finding remains in the scientific record as a concerning data point. EFSA's 2010 safety evaluation of Indigo Carmine (E132) reached an unusual conclusion: it could not establish an ADI due to data limitations, including the brain tumor findings. This means EFSA adopted an implicit conservative position — it neither declared Blue 2 safe nor formally banned it, but the absence of an established ADI signals scientific uncertainty. In medical diagnostic use, high intravenous doses of Indigo Carmine can cause hypertension, bradycardia, and in rare cases anaphylaxis. These are dose-specific clinical pharmacological effects, not relevant to dietary consumption at food use levels. Blue 2 was not included in the 2007 Lancet hyperactivity study. Limited direct research links Blue 2 to behavioral effects. The FDA's April 2025 announcement includes Blue 2 in the class of petroleum-based synthetic dyes to be phased out of the US food supply, reflecting updated policy on the category rather than specific new Blue 2 toxicity data.

Sodium Benzoate: Sodium benzoate's most significant documented concern is the benzene formation reaction. When sodium benzoate coexists with ascorbic acid (vitamin C) in acidic conditions, they react in the presence of metal ions (iron, copper) and UV light to produce benzene, an IARC Group 1 human carcinogen. FDA surveys in 2005-2007 found benzene exceeding the EPA drinking water standard (5 ppb) in 79 of 200 commercial beverages tested. This triggered voluntary reformulations across the beverage industry. The 2007 McCann et al. Lancet study showed that the combination of sodium benzoate with six artificial food dyes significantly increased hyperactivity in children — the effect was synergistic, with the combination producing greater behavioral effects than either ingredient alone. This finding led directly to the EU's mandatory warning label requirement for products combining sodium benzoate with specified dyes. A 2010 study in ADHD: Attention Deficit and Hyperactivity Disorders found associations between urinary sodium benzoate/hippuric acid metabolite levels and ADHD symptom severity in children, independent of dye exposure. A 2019 study in Nutrients (PMC6520673) found similar associations in Korean children. Mitochondrial DNA damage: Dr. Peter Piper at the University of Sheffield found that sodium benzoate at concentrations used in some beverages could damage mitochondrial DNA in yeast cells, potentially affecting mitochondrial function. These findings have not been fully replicated in human tissue studies. Hypersensitivity reactions including urticaria, angioedema, and contact dermatitis are documented. Cross-reactivity with aspirin has been reported in aspirin-sensitive individuals.